Family Medicine Doctors in Amherst, MA Accepting Medicare

29 Family Medicine doctors found. Showing 21 - 29

Katherine J Atkinson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 17 Research Drive, Amherst, MA 01002 Phone: 413-549-8400    Fax: 413-549-8409

Dr. Lynn S Zashin, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 31 Hall Dr, Amherst Medical Center, Amherst, MA 01002 Phone: 413-256-8561    Fax: 413-256-4010

Dr. Ross Sanford Midler, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 31 Hall Dr, Amherst Medical Center, Amherst, MA 01002 Phone: 413-256-8561    Fax: 413-256-4421

Shevaughn M Kealy, M.D Family Medicine Medicare: Medicare Enrolled Practice Location: 170 University Dr, Amherst, MA 01002 Phone: 413-549-7080    Fax: 413-923-9305

Warren H. Morgan, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 150 Infirmary Way, Amherst, MA 01003 Phone: 413-577-5000    Fax: 413-577-5440

Dr. Adam Edwin Kobialka, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 150 Infirmary Way, Amherst, MA 01003 Phone: 413-577-5000    Fax: 413-577-5023

Dr. Pierre Andre Rouzier, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 150 Infirmary Way, Amherst, MA 01003 Phone: 413-577-5000    Fax: 413-577-5023

Dr. Ivan E. Correa, M.D. Family Medicine - Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 150 Infirmary Way, Amherst, MA 01003 Phone: 413-577-5000    Fax: 413-577-3131

Courtney Ellen Nixon, FNP Family Medicine Medicare: Medicare Enrolled Practice Location: 150 Infirmary Way, Amherst, MA 01003 Phone: 413-577-5000    Fax: 413-577-5106

News Archive

Resveratrol shows promise for treating human alcoholic fatty liver disease

The accumulation of fat in the liver as a result of chronic alcohol consumption could be prevented by consuming resveratrol, according to a new study with mice. The research found that resveratrol reduced the amount of fat produced in the liver of mice fed alcohol and, at the same time, increased the rate at which fat within the liver is broken down.

Genzyme announces 2-year data from eliglustat tartrate Phase 2 trial for Gaucher disease

Genzyme Corporation announced today two-year follow-up data from patients enrolled in the phase 2 clinical trial for its investigational oral therapy for Gaucher disease type 1 known as eliglustat tartrate (formerly Genz-112638). Continued improvements were observed across all endpoints, including bone disease, at the two-year timepoint, compared with baseline. The two-year results were presented for the first time today at the Lysosomal Disease Network WORLD Symposium in Miami, Fla.

Language, ethnicity play a role in postoperative behavioral change among chidlren

A study presented at the ANESTHESIOLOGY 2012 annual meeting found children's negative behavioral change after surgery differs among Spanish- and English-speaking White and Hispanic families.

ISO renewal audit for KIKA Clinical Solutions' U.S. and France operations complete

KIKA™ Clinical Solutions announced the successful completion of its ISO renewal audit for its operations in the U.S. and France. KIKA is the leading provider of advanced EDC solutions for Clinical Asset Management™ for the pharmaceutical, biotechnology and medical device markets.

New technique provides closer look at DNA and mRNA

In a study in the advance online edition of Nature Structural and Molecular Biology, researchers from Albert Einstein College of Medicine describe a technique for looking more precisely at a fundamental step of a cell's life - a gene, DNA, being read into a message, mRNA.

Read more Medical News

› Verified 6 days ago

• 1
• 2(current)